Gemtuzumab ozogamicin, Antibody Drug Conjugate Broad approval covering front-line & relapse settings

Editor

7 years ago

Amer M Zeidan, MBBS, Gemtuzumab ozogamicin, Antibody Drug Conjugate Broad approval covering front-line & relapse settings at Imedex Great Debates 2018